BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20811903)

  • 1. Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin.
    Kirschner KM; Sciesielski LK; Scholz H
    Pflugers Arch; 2010 Nov; 460(6):1051-61. PubMed ID: 20811903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene.
    Kirschner KM; Wagner N; Wagner KD; Wellmann S; Scholz H
    J Biol Chem; 2006 Oct; 281(42):31930-9. PubMed ID: 16920711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex life of WT1.
    Wagner KD; Wagner N; Schedl A
    J Cell Sci; 2003 May; 116(Pt 9):1653-8. PubMed ID: 12665546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wilms tumor protein WT1 stimulates transcription of the gene encoding insulin-like growth factor binding protein 5 (IGFBP5).
    Müller M; Persson AB; Krueger K; Kirschner KM; Scholz H
    Gene; 2017 Jul; 619():21-29. PubMed ID: 28366834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation.
    Scholz H; Wagner KD; Wagner N
    Pflugers Arch; 2009 Jun; 458(2):315-23. PubMed ID: 19052773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
    Brett A; Pandey S; Fraizer G
    Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.
    Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA
    Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C; Romaniuk PJ
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.
    Bor YC; Swartz J; Morrison A; Rekosh D; Ladomery M; Hammarskjöld ML
    Genes Dev; 2006 Jun; 20(12):1597-608. PubMed ID: 16738405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C; Englert C; Gessler M
    Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
    Wagner KD; Wagner N; Schley G; Theres H; Scholz H
    Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
    Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
    J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.